While DNA microarrays are already widely used, adapting the technology to RNA microarrays has proved difficult due to the lower stability of RNA. In 2018, the University of Vienna demonstrated how ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.

To address the demand for rapid, highly specific therapeutic candidates, Creative Biolabs has optimized its comprehensive suite of antibody discovery platforms.

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.